ANNX

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 7, 2026

Equibles Rating blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Weak Quant / Vol Very High

Market backdrop VIX 15 · calm Equity put/call 0.55

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +17%

above

Price vs 50-day avg +8%

above

RSI (14) 56

neutral

MACD trend Positive

52-week position 74%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Neutral

1-month return +23%

trailing

6-month return −6%

trailing

YTD return +16%

this year

Relative strength −15%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $5 › 200d $5 — 50d above 200d

Institutional flow Distributing

3 of 216 funds reported for Jun 30 · net -2.4K sh shares

Insider flow Accumulating

Net +$3.4M over 90 days · 0% sells

Short interest Rising

14.83% of float · ▲ +12.2% MoM · 5.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

216 holders — near 3-yr high, broad support

Squeeze score 87

high risk · 0–100

Fundamentals

Weak

EPS growth −33%

Y/Y

Free cash flow $-186.5M

Balance sheet $162.1M

net cash

Quant / Vol

risk profile

Very High

Volatility 78%

annualized · 1-yr

Max drawdown −35%

past year

ATR 7.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+17% Bullish

Price vs 50-day avg

+8% Bullish

RSI (14)

56 Neutral

MACD trend

Positive Bullish

52-week position

74% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $5 › 200d $5 — 50d above 200d

Institutional flow Distributing

3 of 216 funds reported for Jun 30 · net -2.4K sh shares

Insider flow Accumulating

Net +$3.4M over 90 days · 0% sells

Short interest Rising

14.83% of float · ▲ +12.2% MoM · 5.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

216 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $2 Now $6 · 74% 52-wk high $7

vs 200-day avg +17% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
ARCHER II trial enrollment	659	as of July 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ANNX Annexon, Inc. this stock	$1.16B	+15.5%	—	—	14.8%
ONC BeOne Medicines Ltd.	$431.70B	-1.7%	+22179.2%	878.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$123.19B	+7.1%	+46.2%	28.8	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.67B	-13.8%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.85B	+4.4%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

216

% held: 77.9%
Reported: 3 of 216
Top holder: Redmile Group, LLC

Held Float

View

Held by Funds

Fund positions

171

View

Short & Settlement

Short Interest Rising

Shares short

29.6M

Days to cover: 5.4d
Change: +3.2M sh

View

Short Volume

Short vol %

51%

As of: Jul 10, 2026

Short Total

View

Fails to Deliver

FTD shares

126.3K

Value: $687.3K
As of: May 22, 2026

View

Off-Exchange

Off-exchange %

34.7%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net buying

Net (90d)

+$3.4M

Buyers / Sellers: 2 / 0

Buyers Sellers

View

Financials

Net income (FY)

$-206.7M

EPS diluted: $-1.34

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Jun 30, 2026
This year: 11

View

Proposed Sales

Value

$23.5K

Shares: 4.3K
Filed: Mar 2, 2026

View

Exempt Offerings

Offering

$130.5M

Filed: Jul 22, 2022

View

Earnings & Events

Earnings Calls

Last call

Jun 9, 2026

View

	5D	20D	120D	MTD	YTD
ANNX	+6.2%	+22.9%	-5.8%	+1.6%	+15.5%
SPY	+1.4%	+4.1%	+9.1%	+1.1%	+10.7%
vs SPY	+4.9%	+18.8%	-14.9%	+0.5%	+4.8%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance